Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/11/851   
Active ingredient: Glufosfamide
Indication: Treatment of pancreatic cancer
Sponsor: Theradex (Europe) Ltd
2nd Floor, The Pinnacle, Station Way, Crawley, West Sussex RH10 1JH, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/04/2011 Orphan designation EMA/OD/135/10 (2011)2838 of 15/04/2011
8/07/2014 Change of name and/or address of sponsor